Rich countries could be close to normal by the end of 2021 if a COVID-19 vaccine is soon approved and widely used, Microsoft founder Bill Gates said Tuesday.
In an interview with the Wall Street Journal, 64-year-old Gates warned that the vaccines currently being tested in the US are not guaranteed to be successful.
Still, he urged the country to prepare now for ways to reduce public hesitation about its safety, as Americans have growing concerns that the discovery of a vaccine has become too political to be trustworthy.
Gates also targeted the Food and Drug Administration, which embarrassed themselves with misinformation and praise from political figures when they started talking about the use of plasma as a COVID-19 treatment.
Scroll down for video
Microsoft founder Bill Gates claimed Tuesday that the richer countries could go back to normal by the end of 2021 if a vaccine is ready and distributed on a large scale soon
& # 39; The FDA got pretty embarrassed with the Plasma announcement, where it made claims that were just completely wrong. They put in a lot of praise from political figures so they weren't as strong as you'd expect, "Gates claimed.
Still, he said he was behind the agency and trusted the safety of a vaccine.
"With the vaccine and the idea of the panel of experts and the professional team, I think this is the gold standard that both the US and the world should look out for before they start distributing the vaccine to millions of people." he claimed.
COVID-19 vaccines, developed by Pfizer / BioNTech and AstraZeneca / Oxford University, are two of the leading candidates in the race for regulatory approval in the West.
"We still don't know if these vaccines will be successful," said Gates. & # 39; Now it will take some time for capacity to come up. Therefore, the division within the US and between the US and other countries will be a very important point of contention.
"If you go for an elimination where we have no transmission, it will take two to three years," he continued.
"In the rich countries, however, if you really have the vaccine in the first few months of next year, and they're pretty effective at blocking transmission, then you could get things back to normal by the end of next year, that's the best case." 39;
The head of the World Health Organization said Tuesday that a vaccine against COVID-19 could be ready by the end of the year.
Gates, who made a fortune with Microsoft, has since donated $ 36 billion to the Bill & Melinda Gates Foundation to help fight extreme poverty and poor health care.
Last month, the foundation signed an agreement with 16 pharmaceutical companies that Gates said was committed to scaling up production at an unprecedented rate and ensuring that approved vaccines were widely adopted as early as possible.
One of the volunteers who received the COVID-19 vaccine in the Phase 3 studies developed by the University of Oxford in collaboration with UK pharmaceutical company AstraZeneca. One of the leading candidates in the race is to be the first to get regulatory approval in the West
Test kits for the Pfizer Coronavirus Disease Vaccine Study, which is also a leading candidate for the first vaccine to be approved in the West, will be on display at the Research Centers of America
Russia has pushed its COVID-19 vaccine with mass public vaccinations alongside the main human experiment and has raised concerns with some observers that it is prioritizing national prestige over sound science and safety.
"We're also talking to Russia and China," said Gates. "None of their vaccines are in a Phase III study with a highly respected regulatory agency overseeing this study."
Gates said that from a scientific standpoint, the Russian and Chinese vaccines are perfectly valid projects, but the lack of a prestigious Phase III study could limit their appeal outside of their respective countries.
"Western companies are ahead of the curve in doing these Phase III studies, so if these do well and are offered at low cost, I doubt there will be many Russian or Chinese vaccines outside of these countries," he said.
Gates added that ways should be considered in the United States to reduce the hesitation about getting a COVID-19 vaccine when one is ready.
“You know, here in the US we should be thinking about which voices will help reduce the hesitation. And so we can get to a level of vaccination that really has the chance to stop it, ”he commented.
He cited his experience developing a vaccine against polio and the rumors and conspiracy theories associated with it.
"Vaccine reluctance is common in all countries and precedes the pandemic," continued Gates.
“Even with the polio eradication that has been going on for several decades and hopefully nearing completion, we've seen very bad rumors about the polio vaccine as it came from the US and is supposed to sterilize women.
“In places like Nigeria, we had to go to and speak to the religious leaders to have their children vaccinated. So, if you understand the trust network that is an expert, very few people can look directly at the wording and the data. & # 39;
When asked who could best balance competing health and economic needs, Gates said, "South Korea, Australia – since this is an exponential event, a little intelligence early on makes a big difference."
On Tuesday, the chief of Operation Warp Speed, Dr. Moncef Slaoui, US regulators won't read the coronavirus vaccine's effectiveness for the first time until November.
This means the vaccine czar doesn't expect to be able to fire a shot before election day, which destroys President Trump's November 3rd hopes.
Dr. However, Slaoui said he was "comfortable" that a vaccine or two will have been shown to be effective within the next two months and will have enough doses for about 30 million people, he said during a Johns Hopkins webinar Tuesday.
It came just hours after an FDA advisory committee recommended that each coronavirus bite contain safety data for two months before being approved for Emergency Use Authorization (EUA).
The Agency published information documents for the Advisory Committee on Vaccines and Related Biological Products Meeting on COVID-19 vaccinations scheduled for October 22nd.
In addition to the requirements for safety data, the committee has asked vaccine manufacturers to submit their manufacturing process and review information at least one month before submitting an EEA application.
While the recommendations were not made official and the FDA is under no obligation to accept them, they all assure that a shot for the virus that has killed more than 210,000 Americans will not be available until election day.
(tagsToTranslate) Dailymail (t) Nachrichten (t) Coronavirus